# Colombia Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Colombia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Colombia (COL) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $65.4M - Products: 33 - Buyer markets: 26 - Average CAGR: +5.6% - Global sector size: $647.8B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $310.3B | $37.3M | $116.6B | -2.0% | 22 | +0.0% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $121.0B | $8.0K | $48.2B | +33.1% | 8 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.4B | $9.9M | $17.0B | +16.2% | 8 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $29.3B | $1.1M | $15.9B | -4.0% | 6 | +0.0% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $23.0B | $615.6K | $13.6B | +1.8% | 7 | +0.0% | | HS 300220 - Vaccines: for human medicine | $13.0B | $13.9K | $12.6B | -0.7% | 4 | +0.0% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.8B | $5.3K | $11.7B | -15.9% | 2 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $396.2K | $10.7B | -0.8% | 3 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $13.4B | $3.5K | $8.5B | -9.0% | 3 | +0.0% | | HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $6.1B | $8.7K | $8.3B | +22.6% | 2 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $8.6M | $8.0B | +9.9% | 4 | +0.1% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $9.3B | $84.8K | $7.4B | +39.7% | 3 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.1B | $2.7K | $6.3B | +4.1% | 3 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $18.5 | $5.0B | -30.9% | 1 | +0.0% | | HS 330300 - Perfumes and toilet waters | $6.6B | $1.4M | $4.1B | +13.4% | 2 | +0.0% | | HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $3.1B | $114.1 | $2.9B | -20.3% | 2 | +0.0% | | HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $1.5B | $93.1K | $2.1B | -3.2% | 1 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $3.7K | $2.0B | -4.7% | 1 | +0.0% | | HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $6.7K | $2.0B | +1.0% | 1 | +0.0% | | HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $698.7K | $1.9B | +20.5% | 1 | +0.1% | | HS 281820 - Aluminium oxide: other than artificial corundum | $2.2B | $68.9 | $1.8B | -39.6% | 1 | +0.0% | | HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $1.7B | $12.3K | $1.7B | -8.2% | 1 | +0.0% | | HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $5.1M | $1.7B | +11.3% | 1 | +0.3% | | HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $93.6 | $1.4B | +1.3% | 1 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $3.2 | $1.4B | +54.7% | 1 | +0.0% | | HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $3.6K | $1.3B | +14.8% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $38.8K | $1.2B | +24.2% | 1 | +0.0% | | HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $2.2B | $4.9 | $1.2B | +44.2% | 1 | +0.0% | | HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.1 | $1.1B | -34.3% | 1 | +0.0% | | HS 290250 - Cyclic hydrocarbons: styrene | $768.8M | $28.2K | $1.1B | +31.5% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $2.4K | $1.0B | -0.9% | 1 | +0.0% | | HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $996.0 | $997.2M | -8.9% | 1 | +0.0% | | HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $1.1K | $990.0M | -6.3% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $91.6B calculated opportunity across 18 products. - Switzerland, Liechtenstein (CHE): $37.8B calculated opportunity across 5 products. - Germany (DEU): $34.2B calculated opportunity across 10 products. - Belgium (BEL): $20.5B calculated opportunity across 4 products. - China (CHN): $16.6B calculated opportunity across 6 products. - Netherlands (NLD): $15.7B calculated opportunity across 5 products. - France (FRA): $11.5B calculated opportunity across 6 products. - Mexico (MEX): $11.3B calculated opportunity across 6 products. - Spain (ESP): $10.3B calculated opportunity across 5 products. - Italy (ITA): $9.8B calculated opportunity across 2 products. - Slovenia (SVN): $9.7B calculated opportunity across 1 products. - Canada (CAN): $9.3B calculated opportunity across 5 products. ## Growth stars - HS 340220: +54.7% average CAGR, $1.4B calculated opportunity. - HS 300214: +44.2% average CAGR, $1.2B calculated opportunity. - HS 382600: +39.7% average CAGR, $7.4B calculated opportunity. - HS 300215: +33.1% average CAGR, $48.2B calculated opportunity. - HS 290250: +31.5% average CAGR, $1.1B calculated opportunity. - HS 300390: +24.2% average CAGR, $1.2B calculated opportunity. - HS 293379: +22.6% average CAGR, $8.3B calculated opportunity. - HS 382319: +20.5% average CAGR, $1.9B calculated opportunity. - HS 382499: +16.2% average CAGR, $17.0B calculated opportunity. - HS 290110: +14.8% average CAGR, $1.3B calculated opportunity. ## Diversification opportunities - HS 300490: 22 buyer markets, $116.6B calculated opportunity. - HS 300215: 8 buyer markets, $48.2B calculated opportunity. - HS 382499: 8 buyer markets, $17.0B calculated opportunity. - HS 300439: 7 buyer markets, $13.6B calculated opportunity. - HS 300212: 6 buyer markets, $15.9B calculated opportunity. - HS 300220: 4 buyer markets, $12.6B calculated opportunity. - HS 330499: 4 buyer markets, $8.0B calculated opportunity. - HS 330210: 3 buyer markets, $10.7B calculated opportunity. - HS 293499: 3 buyer markets, $8.5B calculated opportunity. - HS 382600: 3 buyer markets, $7.4B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.